(updated to add analyst comment)Baird analyst Madhu Kumar initiates coverage on Cellular Biomedicine Group (NASDAQ: CBMG) with a Outperform rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE